These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9793975)

  • 1. Hyperglycosylated hCG, a potential alternative to hCG in Down syndrome screening.
    Cole LA; Omrani A; Cermik D; Singh RO; Mahoney MJ
    Prenat Diagn; 1998 Sep; 18(9):926-33. PubMed ID: 9793975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary screening tests for fetal Down syndrome: II. Hyperglycosylated hCG.
    Cole LA; Shahabi S; Oz UA; Rinne KM; Omrani A; Bahado-Singh RO; Mahoney MJ
    Prenat Diagn; 1999 Apr; 19(4):351-9. PubMed ID: 10327141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
    Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
    Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal urine hyperglycosylated hCG in pregnancies with Down syndrome.
    Cuckle HS; Shahabi S; Sehmi IK; Jones R; Cole LA
    Prenat Diagn; 1999 Oct; 19(10):918-20. PubMed ID: 10521815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
    Palomaki GE; Neveux LM; Haddow JE; Wyatt P
    Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
    Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
    Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening.
    Cole LA; Shahabi S; Oz UA; Bahado-Singh RO; Mahoney MJ
    Clin Chem; 1999 Dec; 45(12):2109-19. PubMed ID: 10585342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary hyperglycosylated hCG in first trimester screening for chromosomal abnormalities.
    Weinans MJ; Butler SA; Mantingh A; Cole LA
    Prenat Diagn; 2000 Dec; 20(12):976-8. PubMed ID: 11113909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester intact hCG as an early marker of trisomy 21: a promise unrecognised?
    Spencer K; Cowans NJ; Uldbjerg N; Vereecken A; Tørring N
    Prenat Diagn; 2008 Dec; 28(12):1156-9. PubMed ID: 19006100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serum markers in first-trimester down syndrome screening.
    Canick JA; Lambert-Messerlian GM; Palomaki GE; Neveux LM; Malone FD; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Saade GR; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Obstet Gynecol; 2006 Nov; 108(5):1192-9. PubMed ID: 17077242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid-deficient invasive trophoblast antigen (sd-ITA): a new urinary variant for gestational Down syndrome screening.
    Sutton JM; Cole LA
    Prenat Diagn; 2004 Mar; 24(3):194-7. PubMed ID: 15057952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy.
    Hsu JJ; Spencer K; Aitken DA; Crossley J; Choi T; Ozaki M; Tazawa H
    Prenat Diagn; 1999 Feb; 19(2):146-58. PubMed ID: 10215073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single serum test for measuring early pregnancy outcome with high predictive value.
    Sutton-Riley JM; Khanlian SA; Byrn FW; Cole LA
    Clin Biochem; 2006 Jul; 39(7):682-7. PubMed ID: 16765931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycosylated hCG: a variant with separate biological functions to regular hCG.
    Cole LA; Khanlian SA
    Mol Cell Endocrinol; 2007 Jan; 260-262():228-36. PubMed ID: 17081684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
    Wald NJ; Morris JK; Ibison J; Wu T; George LM
    Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.